Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 12Esophageal Squamous Cell Carcinoma 4Carcinoma, Transitional Cell 3Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Triple Negative Breast Neoplasms 1Treatment-naive Advanced Non-small Cell Lung Cancer 1Small Cell Lung Carcinoma 1Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1Recurrence 1Radiotherapy 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Locally Advanced or Metastatic GC and GCJ Adenocarcinoma 1Hodgkin Disease 1Esophageal Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Cholangiocarcinoma 1Cervical Cancer Metastatic 1Carcinoma, Renal Cell 1Breast Neoplasms 1Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy 1

Interventions

toripalimab 1Sorafenib 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Radiotherapy × toripalimab × Clear all
NCT04709380 2025-02-26

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Terminated
36 enrolled
Gastrointestinal

Radiotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡